David L. Lucchino
Board Member
Korro Bio, Inc. (KRRO)Equibles does not estimate personal net worth.
Get an email with a short summary when Korro Bio, Inc. publishes a filing, an earnings call transcript or a press release.
Get KRRO alertsAbout David L. Lucchino
David L. Lucchino is recorded as Board Member at Korro Bio, Inc. (KRRO) since November 3, 2023 and CEO at Korro Bio, Inc. (KRRO). The newest filing on record that lists David L. Lucchino as CEO at Korro Bio, Inc. (KRRO) is dated April 29, 2022. Korro Bio, Inc. reported in an 8-K filed August 28, 2024 that David L. Lucchino resigned as member of our Board of Directors, effective August 26, 2024. Korro Bio, Inc. reported in an 8-K filed November 6, 2023 that David L. Lucchino was appointed Board (Class I director), effective November 3, 2023. Korro Bio, Inc. reported in an 8-K filed November 6, 2023 that David L. Lucchino resigned as President and Chief Executive Officer and principal executive officer, effective November 3, 2023. The proxy statement of Korro Bio, Inc. reports total compensation of $3,878,265 for David L. Lucchino in fiscal 2023, including a base salary of $558,767. Disclosed compensation is on record for 6 fiscal years. Korro Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Korro Bio, Inc. includes Christopher Loose (CEO), Ram Aiyar (CEO, CFO and Board Member), Nessan Bermingham (Chairman and Board Member) and 7 others.
“On August 26, 2024, David L. Lucchino, a member of our Board of Directors, or the Board, notified us that he resigned from the Board, effective immediately.”
“Effective upon the closing of the Merger on November 3, 2023, the Board was reconstituted as follows: (i) David L. Lucchino (designated by Frequency), (ii) Ram Aiyar, Ali Behbahani, Nessan Bermingham and Jean-Francois Formela (designated by Legacy Korro) and (iii) Timothy Pearson (designated by mutual agreement), with one vacancy for an additional independent director once identified.”
Affiliation history
-
Current
2023-11-03–present
-
Current
Start not stated–present
Last confirmed April 29, 2022
-
2023-11-03–2024-08-26
-
2014-01-01–2024-08-26
Company network
Leadership on record at Korro Bio, Inc.
- Christopher Loose CEO
- Ram Aiyar CEO, CFO, Board Member
- Nessan Bermingham Chairman, Board Member
- Peter P. Pfreundschuh CFO
- Richard M. Mitrano CFO, Chief Accounting Officer
- Vineet Agarwal CFO
- Todd Chappell COO
- Steve Colletti CTO
- Jeffrey Cerio General Counsel
- Michael D. Bookman General Counsel
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Korro Bio, Inc. (KRRO) | Former President and Chief Executive Officer | $558,767 | $3,878,265 |
| 2022 | Korro Bio, Inc. (KRRO) | Former President and Chief Executive Officer | $630,000 | $3,159,278 |
| 2021 | Korro Bio, Inc. (KRRO) | President and Chief Executive Officer | $600,000 | $5,821,532 |
| 2020 | Korro Bio, Inc. (KRRO) | President and Chief Executive Officer | $551,250 | $5,217,638 |
| 2019 | Korro Bio, Inc. (KRRO) | President and Chief Executive Officer | $441,667 | $7,364,604 |
| 2018 | Korro Bio, Inc. (KRRO) | President and Chief Executive Officer | $367,262 | $743,700 |